Trial Profile
Retrospective study of all-cause mortality between patients with direct oral anticoagulants and warfarin for the primary treatment of venous thromboembolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions
- 20 Aug 2018 New trial record
- 13 Aug 2018 Results published in the Thrombosis and Haemostasis